Objective:

To report a case of invasive tracheal mucormycosis in a patient with diabetic ketosis.

Approach:

Key Findings:

• Invasive tracheal mucormycosis is associated with high mortality.
• Early clinical manifestations are often nonspecific.
• Patients may experience irreversible airway damage and long-term dependence on tracheostomy.

Interpretation:

Mucormycosis should be considered in diabetic patients with necrotizing airway lesions and non-response to antibiotics.

Limitations:

• The case study is based on a single patient, limiting generalizability.
• Long-term outcomes and airway management strategies post-infection are not well-documented.

Conclusion:

Airway function preservation and long-term prognostic assessment are important in managing patients with invasive tracheal mucormycosis.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.